Subsequent reductions in insurance prices irritate the domestic pharmaceutical industry

Pharmaceutical industry observers say that many domestic pharmaceutical firms, which have been heavily dependent on the exclusive wholesaling business due to their fragile distribution structure in the regional areas, will be subject to subsequent reductions in medical insurance prices, unless that they are directly engaged in the drug sales or change the current transaction practice.

Accord...